Apollo Hospitals, Siemens Healthineers Partner to Boost Liver Care Innovation

Apollo Hospitals, Siemens Healthineers Partner to Boost Liver Care Innovation

The collaboration brings together clinical and technological strengths to create innovative solutions for India’s rising liver diseases including MASLD.

Siemens Healthineers, a German multinational medtech company has joined hands with Apollo Hospitals to conduct research on advanced innovations in artificial intelligence (AI) and imaging technologies in healthcare.

The research, spanning quantitative ultrasound imaging to AI-driven clinical solutions, aims to enhance liver disease management by improving patient care pathways and outcomes.

Ranging from early detection and risk stratification to monitoring intervention and therapy response, the research focuses on early diagnosis, accurate detection, and precise monitoring to improve patient outcomes.

As per Government of India guidelines, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), is a growing cause of liver disease in India. Its prevalence ranges from 9 per cent to 32 per cent and is higher among individuals who are overweight, obese, or have diabetes.

The collaboration brings together clinical and technological strengths to create innovative solutions for India’s rising liver diseases including MASLD.

Sangita Reddy, Apollo Hospitals joint Managing Director said, “Our collaboration with Siemens Healthineers is a transformative step in using AI to redefine non-invasive diagnostics for liver disease.”

AI-driven disease progression models shall play a pivotal role in early detection of fibrosis, allowing timely interventions, cost-effective screening, and improved patient outcomes, Reddy added.

Hariharan Subramanian, Managing Director at Siemens Healthcare, said, “ We believe that advanced technologies will aid timely and precise diagnosis, leading to better disease management and improving the quality of life for patients. Our joint effort will help address the unmet needs in liver disease diagnosis and treatment, and we look forward to a fruitful partnership.”

Stay tuned for more such updates on Digital Health News

Follow us

More Articles By This Author


Show All

Sign In / Sign up